Understanding cellular senescence: pathways involved, therapeutics and longevity aiding

References

• Campisi J, Kapahi P, Lithgow GJ, et al. From discoveries in ageing research to therapeutics for healthy ageing. Nature. 2019;571(7764):183.
   PubMed Web of Science ®Google Scholar
• McCay CM, Maynard LA, Sperling G, et al. Nutrition reviews. Volume 18 July–December, 1975. Pages 1–13. Retarded growth, life span, ultimate body size and age changes in the albino rat after feeding diets restricted in calories. J Nutr. 1939;18(1):1–13. doi: 10.1093/jn/18.1.1
   Google Scholar
• Mattison JA, Colman RJ, Beasley TM, et al. Caloric restriction improves health and survival of rhesus monkeys. Nat Commun. 2017;8 [[cited 2022 Oct 31]]. https://pubmed.ncbi.nlm.nih.gov/28094793/
   PubMed Web of Science ®Google Scholar
• Pifferi F, Terrien J, Marchal J, et al. Caloric restriction increases lifespan but affects brain integrity in grey mouse lemur primates. Commun Biol Internet. 2018;1 [cited 2022 Oct 31]. /pmc/articles/PMC6123706/
   PubMed Web of Science ®Google Scholar
• Omodei D, Fontana L. Calorie restriction and prevention of age-associated chronic disease. FEBS Lett. 2011;585(11):1537–1542. doi: 10.1016/j.febslet.2011.03.015
   PubMed Web of Science ®Google Scholar
• Hayflick L, Moorhead PS. The serial cultivation of human diploid cell strains. Exp Cell Res. 1961;25(3):585–621. doi: 10.1016/0014-4827(61)90192-6
   PubMed Web of Science ®Google Scholar
• Hayflick L. The limited in vitro lifetime of human diploid cell strains. Exp Cell Res. 1965;37(3):614–636. doi: 10.1016/0014-4827(65)90211-9
   PubMed Web of Science ®Google Scholar
• Shay JW, Wright WE. Hayflick, his limit, and cellular ageing. Nat Rev Mol Cell Biol. 2000;1(1):72–76. doi: 10.1038/35036093
   PubMed Web of Science ®Google Scholar
• López-Otín C, Blasco MA, Partridge L, et al. The Hallmarks of ageing. Cell. 2013;153:1194–1217. doi: 10.1016/j.cell.2013.05.039
   PubMed Web of Science ®Google Scholar
• Muñoz-Espín D, Serrano M. Cellular senescence: from physiology to pathology. Nat Rev Mol Cell Biol. 2014;15(7):482–496. 2014; 15. doi: 10.1038/nrm3823
   PubMed Web of Science ®Google Scholar
• Hudgins AD, Tazearslan C, Tare A, et al. Age- and tissue-specific expression of senescence biomarkers in mice. Front Genet Internet. 2018 [[cited 2022 Nov 7]];9. doi: 10.3389/fgene.2018.00059
   PubMed Web of Science ®Google Scholar
• Blumenthal EJ, Mille ACK, Malkinson AM. eonine protein kinase m-dependent proteasc senescent IMR-90 fibrobla fib. Mech Ageing Dev. 1993;72:13–24. doi: 10.1016/0047-6374(93)90127-D
   PubMedGoogle Scholar
• Chen Q, Ames BN. Senescence-like growth arrest induced by hydrogen peroxide in human diploid fibroblast F65 cells (replicatlve castion/mophol/DNA damage/p53 cell cycle checkpoint). Cell Bio. 1994;91:4130–4134. doi: 10.1073/pnas.91.10.4130
   Google Scholar
• Medrano EE, Yang F, Boissy R, et al. Terminal differentiation and senescence in the human melanocyte: repression of tyrosine-phosphorylation of the extracellular signal-regulated kinase 2 selectively defines the two phenotypes. ?Mol Biol Cell. 1994;5(4):497–509.
   Web of Science ®Google Scholar
• Toussaint O, Remacle J, Dierick JF, et al. From the Hayflick mosaic to the mosaics of ageing.: role of stress-induced premature senescence in human ageing. Int J Biochem Cell Biol. 2002;34(11):1415–1429.
   PubMed Web of Science ®Google Scholar
• Xu M, Tchkonia T, Ding H, et al. JAK inhibition alleviates the cellular senescence-associated secretory phenotype and frailty in old age. Proc Natl Acad Sci USA. 2015;112:E6301–10. doi: 10.1073/pnas.1515386112
   PubMed Web of Science ®Google Scholar
• Debacq-Chainiaux F, Ben Ameur R, Bauwens E, et al. Stress-induced (premature) senescence. In: Rattan S, Hayflick L, editors. Cellular Ageing and Replicative Senescence. Vol. 4, Springer; 2016. p. 243–262.
   Google Scholar
• Campisi J. Cellular senescence and apoptosis: how cellular responses might influence ageing phenotypes. Exp Gerontol. 2003;38:5–11. doi: 10.1016/S0531-5565(02)00152-3
   PubMed Web of Science ®Google Scholar
• Giaimo S, d’Adda di Fagagna F. D’Adda di Fagagna F. is cellular senescence an example of antagonistic pleiotropy? Ageing Cell. 2012;11:378–383. doi: 10.1111/j.1474-9726.2012.00807.x
   PubMed Web of Science ®Google Scholar
• Davidovic M, Sevo G, Svorcan P, et al. Old age as a privilege of the “selfish ones. Aging Dis. 2010;1:139.
   PubMed Web of Science ®Google Scholar
• Jin K. Modern biological theories of ageing. Aging Dis. 2010;1:72.
   PubMed Web of Science ®Google Scholar
• Rossi M, Abdelmohsen K. The emergence of senescent surface biomarkers a iss senotherapeutic targets. Cells. 2021 [[cited 2022 Nov 1]];10:1740. /pmc/articles/PMC8305747/ 10.3390/cells10071740.
   PubMed Web of Science ®Google Scholar
• Dimri GP, Lee X, Basile G, et al. A biomarker that identifies senescent human cells in culture and in ageing skin in vivo. Proc Natl Acad Sci USA. 1995;92:9363–9367. doi: 10.1073/pnas.92.20.9363
   PubMed Web of Science ®Google Scholar
• Althubiti M, Lezina L, Carrera S, et al. Characterization of novel markers of senescence and their prognostic potential in cancer. Cell Death Dis 5:11 2014. 2014;5:e1528–e1528. doi: 10.1038/cddis.2014.489
   PubMed Web of Science ®Google Scholar
• von Zglinicki T. Telomeres: influencing the rate of ageing. Ann N Y Acad Sci. 1998;854:318–327. doi: 10.1111/j.1749-6632.1998.tb09912.x
   PubMed Web of Science ®Google Scholar
• Kaneko T, Tahara S, Matsuo M. Non-linear accumulation of 8-hydroxy-2’-deoxyguanosine, a marker of oxidized DNA damage, during ageing. Mutat Res DNAging Genet Instab Aging. 1996;316:277–285. doi: 10.1016/S0921-8734(96)90010-7
   PubMed Web of Science ®Google Scholar
• Burton DGA, Krizhanovsky V. Physiological and pathological consequences of cellular senescence. Cell Mol Life Sci. 2014;71(22):4373–4386. doi: 10.1007/s00018-014-1691-3
   PubMed Web of Science ®Google Scholar
• Adams PD. Healing and hurting: molecular mechanisms, functions, and pathologies of cellular senescence. Molecular Cell. 2009;36(1):2–14. doi: 10.1016/j.molcel.2009.09.021
   PubMed Web of Science ®Google Scholar
• Campisi J, D’Adda Di Fagagna F. Cellular senescence: when bad things happen to good cells. Nat Rev Mol Cell Biol. 2007;8(9):729–740. 2007; 8. doi: 10.1038/nrm2233
   PubMed Web of Science ®Google Scholar
• Lanigan F, Geraghty JG, Bracken AP. Transcriptional regulation of cellular senescence. Oncogene. 2011;30:2901–2911. 30:26 2011. doi: 10.1038/onc.2011.34.
   PubMed Web of Science ®Google Scholar
• Weinberg RA. The retinoblastoma protein and cell cycle control. Cell. 1995;81(3):323–330. doi: 10.1016/0092-8674(95)90385-2
   PubMed Web of Science ®Google Scholar
• Sherr CJ. Cancer cell cycles. Science. 1996;274(5293):1672–1677. doi: 10.1126/science.274.5293.1672
   PubMed Web of Science ®Google Scholar
• Sherr CJ, McCormick F. The RB and p53 pathways in cancer. Cancer Cell. 2002;2(2):103–112. doi: 10.1016/S1535-6108(02)00102-2
   PubMed Web of Science ®Google Scholar
• Wagner V, Gil J. Senescence as a therapeutically relevant response to CDK4/6 inhibitors. Oncogene. 2020;39(29):5165–5176. doi: 10.1038/s41388-020-1354-9
   PubMed Web of Science ®Google Scholar
• Baus F, Gire V, Fisher D, et al. Permanent cell cycle exit in G2 phase after DNA damage in normal human fibroblasts. EMBO J. 2003;22:3992–4002. doi: 10.1093/emboj/cdg387
   PubMed Web of Science ®Google Scholar
• Wiebusch L, Hagemeier C. p53- and p21-dependent premature APC/C-Cdh1 activation in G2 is part of the long-term response to genotoxic stress. Oncogene. 2010;29:3477–3489. doi: 10.1038/onc.2010.99
   PubMed Web of Science ®Google Scholar
• Müllers E, Silva Cascales H, Jaiswal H, et al. Nuclear translocation of cyclin B1 marks the restriction point for terminal cell cycle exit in G2 phase. Cell Cycle. 2014;13(17):2733–2743.
   PubMed Web of Science ®Google Scholar
• Krenning L, Feringa FM, Shaltiel IA, et al. Transient activation of p53 in G2 phase is sufficient to induce senescence. Mol Cell. 2014;55(1):59–72.
   PubMed Web of Science ®Google Scholar
• Gire V, Dulic V. Senescence from G2 arrest, revisited. Cell Cycle. 2015;14(3):297–304. doi: 10.1080/15384101.2014.1000134
   PubMed Web of Science ®Google Scholar
• Gillis LD, Leidal AM, Hill R, et al. p21Cip1/WAF1 mediates cyclin B1 degradation in response to DNA damage. Cell Cycle. 2009;8(2):253–256.
   PubMed Web of Science ®Google Scholar
• Nakayama Y, Yamaguchi N. Role of cyclin B1 levels in DNA damage and DNA damage-induced senescence. Int Rev Cell Mol Biol. 2013;305:303–337.
   PubMed Web of Science ®Google Scholar
• Johmura Y, Shimada M, Misaki T, et al. Necessary and sufficient role for a mitosis skip in senescence induction. Mol Cell. 2014;55(1):73–84.
   PubMed Web of Science ®Google Scholar
• Krenning L, Medema RH. Enter the nucleus to exit the cycle. Cell Cycle. 2014;13(17):2651–2652. doi: 10.4161/15384101.2014.948783
   PubMed Web of Science ®Google Scholar
• Müllers E, Silva Cascales H, Burdova K, et al. Residual Cdk1/2 activity after DNA damage promotes senescence. Ageing Cell. 2017;16:575–584. doi: 10.1111/acel.12588
   PubMed Web of Science ®Google Scholar
• Dimri GP, Lee X, Basile G, et al. A biomarker that identifies senescent human cells in culture and in ageing skin in vivo. Proc Nat Acad Sci. 1995;92:9363–9367. doi: 10.1073/pnas.92.20.9363
   PubMed Web of Science ®Google Scholar
• Stein GH, Beeson M, Gordon L. Failure to phosphorylate the retinoblastoma gene product in senescent human fibroblasts. Science. 1990;249(4969):666–669. doi: 10.1126/science.2166342
   PubMed Web of Science ®Google Scholar
• Collado M, Blasco MA, Serrano M. Cellular senescence in cancer and ageing. Cell. 2007;130:223–233. doi: 10.1016/j.cell.2007.07.003
   PubMed Web of Science ®Google Scholar
• Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646–674. doi: 10.1016/j.cell.2011.02.013
   PubMed Web of Science ®Google Scholar
• Kumari R, Jat P. Mechanisms of cellular senescence: cell cycle arrest and senescence associated secretory phenotype. Front Cell Dev Biol. 2021:485. doi: 10.3389/fcell.2021.645593
   Web of Science ®Google Scholar
• Zindy F, Quelle DE, Roussel MF, et al. Expression of the p16INK4a tumour suppressor versus other INK4 family members during mouse development and ageing. Oncogene. 1997;15:203–211. doi: 10.1038/sj.onc.1201178
   PubMed Web of Science ®Google Scholar
• Krishnamurthy J, Torrice C, Ramsey MR, et al. Ink4a/Arf expression is a biomarker of ageing. J Clin Investig. 2004;114:1299–1299. doi: 10.1172/JCI22475
   PubMed Web of Science ®Google Scholar
• Zeng N, Yang K-T, Bayan J-A, et al. PTEN controls β-cell regeneration in aged mice by regulating cell cycle inhibitor p16ink4a. Ageing Cell. 2013;12:1000–1011. doi: 10.1111/acel.12132
   PubMed Web of Science ®Google Scholar
• Min EY, Kim IH, Lee J, et al. The effects of fucodian on senescence are controlled by the p16INK4a-pRb and p14Arf-p53 pathways in hepatocellular carcinoma and hepatic cell lines. Int J Oncol. 2014;45(1):47–56. doi: 10.3892/ijo.2014.2426
   PubMed Web of Science ®Google Scholar
• Hobson S, Arefin S, Kublickiene K, et al. Senescent cells in early vascular ageing and bone disease of chronic kidney disease—A novel target for treatment. Toxins (Basel). 2019;11:11. InternetAvailable from: https://pubmed.ncbi.nlm.nih.gov/30717151/
   PubMed Web of Science ®Google Scholar
• Mijit M, Caracciolo V, Melillo A, et al. Role of p53 in the regulation of cellular senescence. Biomolecules Internet. 2020;10:420. /pmc/articles/PMC7175209/. doi: 10.3390/biom10030420.
   PubMed Web of Science ®Google Scholar
• Sharpless NE, Sherr CJ. Forging a signature of in vivo senescence. Nat Rev Cancer. 2015;15(7):397–408. doi: 10.1038/nrc3960
   PubMed Web of Science ®Google Scholar
• Debacq-Chainiaux F, Erusalimsky JD, Campisi J, et al. Protocols to detect senescence-associated beta-galactosidase (SA-βgal) activity, a biomarker of senescent cells in culture and in vivo. Nat Protoc. 2009;4:1798–1806. 4:12 2009. doi: 10.1038/nprot.2009.191.
   PubMed Web of Science ®Google Scholar
• Severino J, Allen RG, Balin S, et al. Is β-galactosidase staining a marker of senescence in vitro and in vivo? Exp Cell Res. 2000;257(1):162–171.
   PubMed Web of Science ®Google Scholar
• Lee BY, Han JA, Im JS, et al. Senescence-associated β-galactosidase is lysosomal β-galactosidase. Ageing Cell. 2006;5:187–195. doi: 10.1111/j.1474-9726.2006.00199.x
   PubMed Web of Science ®Google Scholar
• Biran A, Zada L, Karam PA, et al. Quantitative identification of senescent cells in ageing and disease. Ageing Cell. 2017;16:661–671. doi: 10.1111/acel.12592
   PubMed Web of Science ®Google Scholar
• Aksenova AY, Mirkin SM. At the beginning of the end and in the middle of the beginning: structure and maintenance of telomeric DNA repeats and interstitial telomeric sequences. Genes. 2019;10:118. 2019; 10:118. doi: 10.3390/genes10020118.
   PubMed Web of Science ®Google Scholar
• Tomita K. How long does telomerase extend telomeres? Regulation of telomerase release and telomere length homeostasis. Curr Genet. 2018;64:1177–1181. doi: 10.1007/s00294-018-0836-6
   PubMed Web of Science ®Google Scholar
• Srinivas N, Rachakonda S, Kumar R. Telomeres and telomere length: a General overview. Cancers. 2020;12:558. 2020; 12:558. doi: 10.3390/cancers12030558.
   PubMed Web of Science ®Google Scholar
• Oikawa S, Kawanishi S. Site-specific DNA damage at GGG sequence by oxidative stress may accelerate telomere shortening. FEBS Lett. 1999;453(3):365–368. doi: 10.1016/S0014-5793(99)00748-6
   PubMed Web of Science ®Google Scholar
• Barnes RP, Fouquerel E, Opresko PL. The impact of oxidative DNA damage and stress on telomere homeostasis. Mech Ageing Dev. 2019;177:37–45. doi: 10.1016/j.mad.2018.03.013
   PubMed Web of Science ®Google Scholar
• Von Zglinicki T, Wan T, Miwa S. Senescence in post-mitotic cells: a driver of ageing? Antioxid Redox Signal. 2021;34:308–323. doi: 10.1089/ars.2020.8048
   PubMed Web of Science ®Google Scholar
• Bodnar AG, Ouellette M, Frolkis M, et al. Extension of life-span by introduction of telomerase into normal human cells. Science. 1998;279(5349):349–352.
   PubMed Web of Science ®Google Scholar
• Shay JW, Wright WE. Telomeres and telomerase: three decades of progress. Nat Rev Genet. 2019;20:299–309. 20:5 2019. doi: 10.1038/s41576-019-0099-1.
   PubMed Web of Science ®Google Scholar
• Bernardes De Jesus B, Blasco MA. Ageing by telomere loss can be Reversed. Cell Stem Cell. 2011;8:3–4. doi: 10.1016/j.stem.2010.12.013
   PubMed Web of Science ®Google Scholar
• Prieto-Oliveira P. Telomerase activation in the treatment of ageing or degenerative diseases: a systematic review. Mol Cell Biochem. 2021;476:599–607. doi: 10.1007/s11010-020-03929-x
   PubMed Web of Science ®Google Scholar
• Smith-Sonneborn J. Telomerase biology associations offer keys to cancer and ageing therapeutics. Curr Aging Sci. 2019;13:11–21. doi: 10.2174/1874609812666190620124324
   Google Scholar
• Collado M, Serrano M. Senescence in tumours: evidence from mice and humans. Nat Rev Cancer. 2010;10:51–57. 10:1 2010;. doi: 10.1038/nrc2772.
   PubMed Web of Science ®Google Scholar
• Chen W, Kang J, Xia J, et al. p53-related apoptosis resistance and tumour suppression activity in UVB-induced premature senescent human skin fibroblasts. Int J Mol Med. 2008;21:645–653. doi: 10.3892/ijmm.21.5.645
   PubMed Web of Science ®Google Scholar
• Tchkonia T, Zhu Y, Van Deursen J, et al. Cellular senescence and the senescent secretory phenotype: therapeutic opportunities. J Clin Investig. 2013;123(3):966–972.
   PubMed Web of Science ®Google Scholar
• Childs BG, Durik M, Baker DJ, et al. Cellular senescence in ageing and age-related disease: from mechanisms to therapy. Nature Med. 2015;21:1424–1435. doi: 10.1038/nm.4000
   PubMed Web of Science ®Google Scholar
• Dörr JR, Yu Y, Milanovic M, et al. Synthetic lethal metabolic targeting of cellular senescence in cancer therapy. Nature. 2013;501(7467):421–425.
   PubMed Web of Science ®Google Scholar
• Demaria M, Ohtani N, Youssef SA, et al. An essential role for senescent cells in optimal wound healing through secretion of PDGF-AA. Dev Cell. 2014;31(6):722.
   PubMed Web of Science ®Google Scholar
• Jun JI, Lau LF. The matricellular protein CCN1 induces fibroblast senescence and restricts fibrosis in cutaneous wound healing. Nat Cell Biol. 2010;12(7):676–685. doi: 10.1038/ncb2070
   PubMed Web of Science ®Google Scholar
• Sorrentino JA, Krishnamurthy J, Tilley S, et al. p16INK4a reporter mice reveal age-promoting effects of environmental toxicants. J Clin Investig. 2014;124:169–173. doi: 10.1172/JCI70960
   PubMed Web of Science ®Google Scholar
• Baker DJ, Childs BG, Durik M, et al. Naturally occurring p16 Ink4a-positive cells shorten healthy lifespan. Nature. 2016;530:184–189. doi: 10.1038/nature16932
   PubMed Web of Science ®Google Scholar
• Lujambio A. To clear, or not to clear (senescent cells)? That is the question. BioEssays: news and reviews in molecular, cellular and developmental biology. BioEssays. 2016;38(Suppl 1):S56–64. doi: 10.1002/bies.201670910
   PubMedGoogle Scholar
• Valentine JM, Kumar S, Moumen A. A p53-independent role for the MDM2 antagonist nutlin-3 in DNA damage response initiation. BMC Cancer. 2011 [cited 2022 Feb 21];11(1). https://pubmed.ncbi.nlm.nih.gov/21338495/
   PubMedGoogle Scholar
• Liu Y, Leslie PL, Zhang Y. Life and death decision-making by p53 and implications for cancer immunotherapy. Trends Cancer. 2021;7(3):226–239. doi: 10.1016/j.trecan.2020.10.005
   PubMed Web of Science ®Google Scholar
• Sheekey E, Narita M. p53 in senescence – it’s a marathon, not a sprint.FEBS J. 2021 [[cited 2022 Feb 18];290(5):1212–1220. https://onlinelibrary.wiley.com/doi/full/10.1111/febs.16325.
   PubMed Web of Science ®Google Scholar
• Xu Y, Li N, Xiang R, et al. Emerging roles of the p38 MAPK and PI3K/AKT/mTOR pathways in oncogene-induced senescence. Trends Biochem Sci. 2014;39(6):268–276. doi: 10.1016/j.tibs.2014.04.004
   PubMed Web of Science ®Google Scholar
• Jung SH, Hwang HJ, Kang D, et al. mTOR kinase leads to PTEN-loss-induced cellular senescence by phosphorylating p53. Oncogene. 2019;38:1639–1650. doi: 10.1038/s41388-018-0521-8
   PubMed Web of Science ®Google Scholar
• Spallarossa P, Altieri P, Aloi C, et al. Doxorubicin induces senescence or apoptosis in rat neonatal cardiomyocytes by regulating the expression levels of the telomere binding factors 1 and 2. Am J Physiol Heart Circ Physiol. 2009;297:H2169–2181. doi: 10.1152/ajpheart.00068.2009
   PubMed Web of Science ®Google Scholar
• Rufini A, Tucci P, Celardo I, et al. Senescence and ageing: the critical roles of p53. Oncogene. 2013;32:5129–5143. doi: 10.1038/onc.2012.640
   PubMed Web of Science ®Google Scholar
• Al Bitar S, Gali-Muhtasib H. The role of the cyclin dependent kinase inhibitor p21 cip1/waf1 in targeting cancer: molecular mechanisms and novel therapeutics. Cancers [Internet]. 2019;11:11. Available from: https://pubmed.ncbi.nlm.nih.gov/31575057/
   Google Scholar
• Benson EK, Mungamuri SK, Attie O, et al. p53-dependent gene repression through p21 is mediated by recruitment of E2F4 repression complexes. Oncogene. 2014;33:3959–3969. doi: 10.1038/onc.2013.378
   PubMed Web of Science ®Google Scholar
• Yosef R, Pilpel N, Papismadov N, et al. p21 maintains senescent cell viability under persistent DNA damage response by restraining JNK and caspase signalling. EMBO J. 2017;36:2280–2295. doi: 10.15252/embj.201695553
   PubMed Web of Science ®Google Scholar
• Zhang Y, Gao Y, Zhang G, et al. DNMT3a plays a role in switches between doxorubicin-induced senescence and apoptosis of colorectal cancer cells. Intl J Cancer. 2011;128(3):551–561.
   PubMed Web of Science ®Google Scholar
• Aliouat-Denis CM, Dendouga N, Van Den Wyngaert I, et al. p53-independent regulation of p21Waf1/Cip1 expression and senescence by Chk2. Mol Cancer Res. 2005;3:627–634. doi: 10.1158/1541-7786.MCR-05-0121
   PubMed Web of Science ®Google Scholar
• Kiyokawa H, Kineman RD, Manova-Todorova KO, et al. Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27(Kip1). Cell. 1996;85(5):721–732.
   PubMed Web of Science ®Google Scholar
• Nakayama K, Ishida N, Shirane M, et al. Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumours. Cell. 1996;85:707–720. doi: 10.1016/S0092-8674(00)81237-4
   PubMed Web of Science ®Google Scholar
• McKay LK, White JP. The AMPK/p27Kip1 pathway as a novel target to promote autophagy and resilience in aged cells. Cells. 2021;10(6):1430. doi: 10.3390/cells10061430
   PubMed Web of Science ®Google Scholar
• Pruitt SC, Freeland A, Rusiniak ME, et al. Cdkn1b overexpression in adult mice alters the balance between genome and tissue ageing. Nat Commun. 2013;4(1):2626.
   PubMedGoogle Scholar
• Salminen A, Kaarniranta K. AMP-activated protein kinase (AMPK) controls the ageing process via an integrated signalling network. Ageing Res Rev. 2012;11:230–241. doi: 10.1016/j.arr.2011.12.005
   PubMed Web of Science ®Google Scholar
• Cuervo AM. Autophagy and ageing. Trends Genet. 2008;24:604–612. doi: 10.1016/j.tig.2008.10.002
   PubMed Web of Science ®Google Scholar
• Rubinsztein DC, Mariño G, Kroemer G. Autophagy and ageing. Cell. 2011;146:682–695. doi: 10.1016/j.cell.2011.07.030
   PubMed Web of Science ®Google Scholar
• Kang HT, Lee KB, Kim SY, et al. Autophagy Impairment Induces Premature Senescence in Primary Human Fibroblasts. PLoS One. 2011;6(8):e23367. doi: 10.1371/journal.pone.0023367
   PubMed Web of Science ®Google Scholar
• He C, Bassik MC, Moresi V, et al. Exercise–induced BCL2–regulated autophagy is required for muscle glucose homeostasis. Nature. 2012;481:511–515. doi: 10.1038/nature10758
   PubMed Web of Science ®Google Scholar
• Bernet JD, Doles JD, Hall JK, et al. P38 MAPK signalling underlies a cell autonomous loss of stem cell self-renewal in aged skeletal muscle. Nature Med. 2014;20:265. doi: 10.1038/nm.3465
   PubMed Web of Science ®Google Scholar
• Alway SE, Siu PM. Nuclear Apoptosis Contributes to Sarcopenia. Exer Sport Sci Rev. 2008;36(2):51. doi: 10.1097/JES.0b013e318168e9dc
   PubMed Web of Science ®Google Scholar
• Chakravarthy MV, Abraha TW, Schwartz RJ, et al. Insulin-like growth factor-I extends in vitro replicative life span of skeletal muscle satellite cells by enhancing G1/S cell cycle progression via the activation of phosphatidylinositol 3’-kinase/Akt signalling pathway. J Biol Chem. 2000;275:35942–35952. doi: 10.1074/jbc.M005832200
   PubMed Web of Science ®Google Scholar
• Machida S, Booth FW. Increased nuclear proteins in muscle satellite cells in aged animals as compared to young growing animals. Exp Gerontol. 2004;39(10):1521–1525. doi: 10.1016/j.exger.2004.08.009
   PubMed Web of Science ®Google Scholar
• Chakkalakal JV, Jones KM, Basson MA, et al. The aged niche disrupts muscle stem cell quiescence. Nature. 2012;490(7420):355.
   PubMed Web of Science ®Google Scholar
• Besson A, Dowdy SF, Roberts JM. CDK inhibitors: cell cycle regulators and beyond. Dev Cell. 2008;14(2):159–169. doi: 10.1016/j.devcel.2008.01.013
   PubMed Web of Science ®Google Scholar
• Chu IM, Hengst L, Slingerland JM. The Cdk inhibitor p27 in human cancer: prognostic potential and relevance to anticancer therapy. Nat Rev Cancer. 2008;8(4):253–267. doi: 10.1038/nrc2347
   PubMed Web of Science ®Google Scholar
• Wu FY, Wang SE, Sanders ME, et al. Reduction of cytosolic p27(Kip1) inhibits cancer cell motility, survival, and tumourigenicity. Cancer Res. 2006;66:2162–2172. doi: 10.1158/0008-5472.CAN-05-3304
   PubMed Web of Science ®Google Scholar
• Sun X, Shi B, Zheng H, et al. Senescence-associated secretory factors induced by cisplatin in melanoma cells promote non-senescent melanoma cell growth through activation of the ERK1/2-RSK1 pathway. Cell Death Dis. 2018;9(3). https://pubmed.ncbi.nlm.nih.gov/29449532/.
   Google Scholar
• Lopes-Paciencia S, Saint-Germain E, Rowell M-C, et al. The senescence-associated secretory phenotype and its regulation. Cytokine. 2019;117:15–22. doi: 10.1016/j.cyto.2019.01.013
   PubMed Web of Science ®Google Scholar
• Mohamad Kamal NS, Safuan S, Shamsuddin S, et al. Ageing of the cells: insight into cellular senescence and detection methods. Eur J Cell Biol. 2020;99:151108–151108. doi: 10.1016/j.ejcb.2020.151108
   PubMed Web of Science ®Google Scholar
• Waaijer MEC, Parish WE, Strongitharm BH, et al. The number of p16INK4a positive cells in human skin reflects biological age. Ageing Cell. 2012;11:722–725. doi: 10.1111/j.1474-9726.2012.00837.x
   PubMed Web of Science ®Google Scholar
• Herbig U, Ferreira M, Condel L, et al. Cellular senescence in ageing primates. Science. 2006;311:1257. doi: 10.1126/science.1122446
   PubMed Web of Science ®Google Scholar
• Xu M, Palmer AK, Ding H, et al. Targeting senescent cells enhances adipogenesis and metabolic function in old age. Elife. 2015;4:1–19. doi: 10.7554/eLife.12997
   Web of Science ®Google Scholar
• Ogrodnik M, Miwa S, Tchkonia T, et al. Cellular senescence drives age-dependent hepatic steatosis. Nat Commun. 2017 [[cited 2022 Nov 7]];8(1): https://pubmed.ncbi.nlm.nih.gov/28608850/
   PubMedGoogle Scholar
• Surks MI, DeFesi CR. Determination of the cell number of each cell type in the anterior pituitary of Euthyroid and hypothyroid rats 1. Endocrinology. 1977;101(3):946–958. doi: 10.1210/endo-101-3-946
   PubMed Web of Science ®Google Scholar
• Rodier F, Campisi J. Four faces of cellular senescence. J Cell Bio. 2011;192(4):547–556. doi: 10.1083/jcb.201009094
   PubMed Web of Science ®Google Scholar
• Minamino T, Orimo M, Shimizu I, et al. A crucial role for adipose tissue p53 in the regulation of insulin resistance. Nature Med. 2009;15(9):1082–1087. 2009; 15. doi: 10.1038/nm.2014
   PubMed Web of Science ®Google Scholar
• Zhang X, Zhang S, Liu X, et al. Oxidation resistance 1 is a novel senolytic target. Ageing Cell. 2018;17:12780–12780. doi: 10.1111/acel.12780
   Web of Science ®Google Scholar
• Coppé J-P, Desprez P-Y, Krtolica A, et al. The senescence-associated secretory phenotype: the dark side of tumour suppression. Annu Rev Pathol. 2010;5(1):99–118. 10.1146/annurev-pathol-121808-102144
   PubMedGoogle Scholar
• Gorgoulis V, Adams PD, Alimonti A, et al. Cellular Senescence: Defining a Path Forward. Cell. 2019;179(4):813–827.
   PubMed Web of Science ®Google Scholar
• Freund A, Orjalo AV, Desprez P-Y, et al. Inflammatory networks during cellular senescence: causes and consequences. Trends Mol Med. 2010;16(5):238–246.
   PubMed Web of Science ®Google Scholar
• Acosta JC, Banito A, Wuestefeld T, et al. A complex secretory program orchestrated by the inflammasome controls paracrine senescence. Nat Cell Biol. 2013;15(8):978–990.
   PubMed Web of Science ®Google Scholar
• Coppé J-P, Patil CK, Rodier F, et al. Senescence-associated secretory phenotypes Reveal cell-Nonautonomous functions of oncogenic RAS and the p53 tumour suppressor. PLoS Biol. 2008;6:e301–e301. doi: 10.1371/journal.pbio.0060301
   PubMed Web of Science ®Google Scholar
• Coppé J-P, Rodier F, Patil CK, et al. Tumour suppressor and ageing biomarker p16(INK4a) induces cellular senescence without the associated inflammatory secretory phenotype. J Biol Chem. 2011;286:36396–36403. doi: 10.1074/jbc.M111.257071
   PubMed Web of Science ®Google Scholar
• Maciel-Barón LA, Morales-Rosales SL, Aquino-Cruz AA, et al. Senescence associated secretory phenotype profile from primary lung mice fibroblasts depends on the senescence induction stimuli. Age. 2016;38:1–14. 1 2016; 38. doi: 10.1007/s11357-015-9864-z.
   PubMedGoogle Scholar
• Kuilman T, Michaloglou C, Vredeveld LCW, et al. Oncogene-induced senescence relayed by an interleukin-dependent inflammatory network. Cell. 2008;133(6):1019–1031.
   PubMed Web of Science ®Google Scholar
• Acosta JC, O’Loghlen A, Banito A, et al. Chemokine signalling via the CXCR2 receptor reinforces senescence. Cell. 2008;133:1006–1018. doi: 10.1016/j.cell.2008.03.038
   PubMed Web of Science ®Google Scholar
• Rodier F, Coppé J-P, Patil CK, et al. Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion. Nat Cell Biol. 2009;11(8):973–979. 11:8 2009. doi: 10.1038/ncb1909
   PubMed Web of Science ®Google Scholar
• Pazolli E, Alspach E, Milczarek A, et al. Chromatin remodeling underlies the senescence- associated secretory phenotype of tumour stromal fibroblasts that supports cancer progression. Cancer Res. 2012;72:2251–2261. doi: 10.1158/0008-5472.CAN-11-3386
   PubMed Web of Science ®Google Scholar
• Sun Y, Coppé JP, Lam EWF. Cellular senescence: the sought or the unwanted? Trends in molecular medicine. Trends Mol Med. 2018;24(10):871–885. doi: 10.1016/j.molmed.2018.08.002
   PubMed Web of Science ®Google Scholar
• Freund A, Patil CK, Campisi J. p38MAPK is a novel DNA damage response-independent regulator of the senescence-associated secretory phenotype. EMBO J. 2011;30(8):1536–1548. doi: 10.1038/emboj.2011.69
   PubMed Web of Science ®Google Scholar
• Harrison DE, Strong R, Sharp ZD, et al. Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature. 2009;460(7253):392–395. 2009; 460:392–5. doi: 10.1038/nature08221
   PubMed Web of Science ®Google Scholar
• Herranz N, Gallage S, Mellone M, et al. mTOR regulates MAPKAPK2 translation to control the senescence-associated secretory phenotype. Nat Cell Biol. 2015;17(9):1205–1217. 2015; 17. doi: 10.1038/ncb3225
   PubMed Web of Science ®Google Scholar
• Laberge R-M, Sun Y, Orjalo AV, et al. MTOR regulates the pro-tumourigenic senescence-associated secretory phenotype by promoting IL1A translation. Nat Cell Biol. 2014;17(8):1049–1061. 2015; 17. doi: 10.1038/ncb3195
   Web of Science ®Google Scholar
• Narita M, Young ARJ, Arakawa S, et al. Spatial coupling of mTOR and autophagy augments secretory phenotypes. Science. 2011;332(6032):966–970.
   PubMed Web of Science ®Google Scholar
• Young ARJ, Narita M, Narita M. Cell senescence as both a dynamic and a Static phenotype. Methods Mol Biol. 2013;965:1–13.
   PubMedGoogle Scholar
• Herranz N, Gil J. Mechanisms and functions of cellular senescence. J Clin Investig. 2018;128(4):1238–1246. doi: 10.1172/JCI95148
   PubMed Web of Science ®Google Scholar
• Krtolica A, Parrinello S, Lockett S, et al. Senescent fibroblasts promote epithelial cell growth and tumourigenesis: a link between cancer and ageing. Proc Natl Acad Sci, USA. 2001;98(21):12072–12077. doi: 10.1073/pnas.211053698
   PubMed Web of Science ®Google Scholar
• Coppe JP, Kauser K, Campisi J, et al. Secretion of vascular endothelial growth factor by primary human fibroblasts at senescence. J Biol Chem. 2006;281(40):29568–29574.
   PubMed Web of Science ®Google Scholar
• Yoshimoto S, Loo TM, Atarashi K, et al. Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome. Nature. 2013;499(7456):97–101.
   PubMed Web of Science ®Google Scholar
• Di Mitri D, Toso A, Chen JJ, et al. Tumour-infiltrating gr-1+ myeloid cells antagonize senescence in cancer. Nature. 2014;515(7525):134–137.
   PubMed Web of Science ®Google Scholar
• Eggert T, Wolter K, Ji J, et al. Distinct functions of senescence-associated immune responses in liver tumour surveillance and tumour progression. Cancer Cell. 2016;30:533–547. doi: 10.1016/j.ccell.2016.09.003
   PubMed Web of Science ®Google Scholar
• Demaria M, O’Leary MN, Chang J, et al. Cellular senescence promotes adverse effects of chemotherapy and cancer relapse. Cancer Discovery. 2017;7(2):165–176.
   PubMed Web of Science ®Google Scholar
• Kim YH, Choi YW, Lee J, et al. Senescent tumour cells lead the collective invasion in thyroid cancer. Nat Commun. 2017;8(1). [[cited 2022 Feb 21]]. https://pubmed.ncbi.nlm.nih.gov/28489070/
   Google Scholar
• Chen F, Long Q, Fu D, et al. Targeting SPINK1 in the damaged tumour microenvironment alleviates therapeutic resistance. Nat Commun. 2018 [[cited 2022 Feb 21]];9(1): https://pubmed.ncbi.nlm.nih.gov/30333494/
   Google Scholar
• Gilbert LA, Hemann MT. Chemotherapeutic resistance: surviving stressful situations. Cancer Res. 2011;71(15):5062–5066. doi: 10.1158/0008-5472.CAN-11-0277
   PubMed Web of Science ®Google Scholar
• Gilbert LA, Hemann MT. DNA damage-mediated induction of a chemoresistant niche. Cell. 2010;143(3):355–366. doi: 10.1016/j.cell.2010.09.043
   PubMed Web of Science ®Google Scholar
• Bent EH, Gilbert LA, Hemann MT. A senescence secretory switch mediated by PI3K/AKT/mTOR activation controls chemoprotective endothelial secretory responses. Genes Dev. 2016;30(16):1811–1821. doi: 10.1101/gad.284851.116
   PubMed Web of Science ®Google Scholar
• Anerillas C, Abdelmohsen K, Gorospe M. Regulation of senescence traits by MAPKs. Geroscience. 2020;42(2):397–408. doi: 10.1007/s11357-020-00183-3
   PubMed Web of Science ®Google Scholar
• van Deursen JM. The role of senescent cells in ageing. Nature. 2014;509:439–446. doi: 10.1038/nature13193
   PubMed Web of Science ®Google Scholar
• McHugh D, Gil J. Senescence and ageing: Causes, consequences, and therapeutic avenues. J Cell Bio. 2018;217:65–77. doi: 10.1083/jcb.201708092
   PubMed Web of Science ®Google Scholar
• Gong X, Liu A, Ming X, et al. UV-induced interaction between p38 MAPK and p53 serves as a molecular switch in determining cell fate. FEBS Lett. 2010;584(23):4711–4716.
   PubMed Web of Science ®Google Scholar
• Dhillon AS, Hagan S, Rath O, et al. MAP kinase signalling pathways in cancer. Oncogene. 2007;26(22):3279–3290.
   PubMed Web of Science ®Google Scholar
• Pimienta G, Pascual J. Canonical and alternative MAPK signalling. Cell Cycle. 2007;6:2628–2632. doi: 10.4161/cc.6.21.4930
   PubMed Web of Science ®Google Scholar
• Alimbetov D, Davis T, Brook AJC, et al. Suppression of the senescence-associated secretory phenotype (SASP) in human fibroblasts using small molecule inhibitors of p38 MAP kinase and MK2. Biogerontology. 2016;17(2):305–315. doi: 10.1007/s10522-015-9610-z
   PubMed Web of Science ®Google Scholar
• Vermeulen L, De Wilde G, Van Damme P, et al. Transcriptional activation of the NF-kappaB p65 subunit by mitogen- and stress-activated protein kinase-1 (MSK1). EMBO J. 2003;22:1313–1324. doi: 10.1093/emboj/cdg139
   PubMed Web of Science ®Google Scholar
• Reber L, Vermeulen L, Haegeman G, et al. Ser276 phosphorylation of NF-kB p65 by MSK1 controls SCF expression in inflammation. PLoS One. 2009;4(2):e4393. doi: 10.1371/journal.pone.0004393
   PubMed Web of Science ®Google Scholar
• Catanzaro JM, Sheshadri N, Pan J-A, et al. Oncogenic Ras induces inflammatory cytokine production by upregulating the squamous cell carcinoma antigens SerpinB3/B4. Nat Commun. 2014;5(1):3729.
   PubMedGoogle Scholar
• Hydbring P, Bahram F, Su Y, et al. Phosphorylation by Cdk2 is required for Myc to repress Ras-induced senescence in cotransformation. Proc Natl Acad Sci, USA. 2010;107(1):58–63.
   PubMed Web of Science ®Google Scholar
• MacIà A, Vaquero M, Gou-Fàbregas M, et al. Sprouty1 induces a senescence-associated secretory phenotype by regulating NFκB activity: implications for tumourigenesis. Cell Death Diff. 2014;21:333–343. doi: 10.1038/cdd.2013.161
   PubMed Web of Science ®Google Scholar
• Wang W, Martindale JL, Yang X, et al. Increased stability of the p16 mRNA with replicative senescence. EMBO Reports. 2005;6(2):158–164. doi: 10.1038/sj.embor.7400346
   PubMed Web of Science ®Google Scholar
• Wang H, Han L, Zhao G, et al. hnRNP A1 antagonizes cellular senescence and senescence-associated secretory phenotype via regulation of SIRT1 mRNA stability. Ageing Cell. 2016;15:1063–1073. doi: 10.1111/acel.12511
   PubMed Web of Science ®Google Scholar
• Ziaei S, Shimada N, Kucharavy H, et al. MNK1 expression increases during cellular senescence and modulates the subcellular localization of hnRNP A1. Exp Cell Res. 2012;318(5):500–508.
   PubMed Web of Science ®Google Scholar
• Alspach E, Flanagan KC, Luo X, et al. p38MAPK plays a crucial role in stromal-mediated tumourigenesis. Cancer Discovery. 2014;4:716–729. doi: 10.1158/2159-8290.CD-13-0743
   PubMed Web of Science ®Google Scholar
• Wiley CD, Campisi J. From ancient pathways to ageing cells-connecting metabolism and cellular senescence. Cell Metab. 2016;23:1013–1021. doi: 10.1016/j.cmet.2016.05.010
   PubMed Web of Science ®Google Scholar
• Georgilis A, Klotz S, Hanley CJ, et al. PTBP1-mediated alternative splicing regulates the inflammatory secretome and the pro-tumourigenic effects of senescent cells. Cancer Cell. 2018;34:85–102.e9. doi: 10.1016/j.ccell.2018.06.007
   PubMed Web of Science ®Google Scholar
• Noh JH, Kim KM, Laura Idda M, et al. GRSF1 suppresses cell senescence. Ageing. 2018;10:1856–1866. doi: 10.18632/aging.101516
   PubMedGoogle Scholar
• Noh JH, Kim KM, Pandey PR, et al. Loss of RNA-binding protein GRSF1 activates mTOR to elicit a proinflammatory transcriptional program. Nucleic Acids Res. 2019;47(5):2472–2486.
   PubMed Web of Science ®Google Scholar
• Roux PP, Topisirovic I. Signalling pathways involved in the regulation of mRNA translation. Mol Cell Biol [Internet]. 2018;38 [[cited 2021 Nov 26]]. https://pubmed.ncbi.nlm.nih.gov/29610153/
   PubMed Web of Science ®Google Scholar
• Sun X, Shi B, Zheng H, et al. Senescence-associated secretory factors induced by cisplatin in melanoma cells promote non-senescent melanoma cell growth through activation of the ERK1/2-RSK1 pathway. Cell Death Dis [Internet]. 2018 [cited 2021 Nov 25]; 9(3). https://pubmed.ncbi.nlm.nih.gov//29449532/
   Google Scholar
• Tomimatsu K, Narita M. Translating the effects of mTOR on secretory senescence. Nat Cell Biol. 2015;17(10):1230–1232. doi: 10.1038/ncb3244
   PubMed Web of Science ®Google Scholar
• Sadasivam S, DeCaprio JA. The DREAM complex: master coordinator of cell cycle dependent gene expression. Nat Rev Cancer. 2013;13:585. doi: 10.1038/nrc3556
   PubMed Web of Science ®Google Scholar
• Litovchick L, Sadasivam S, Florens L, et al. Evolutionarily conserved multisubunit RBL2/p130 and E2F4 protein complex represses human cell cycle-dependent genes in quiescence. Molecular Cell. 2007;26(4):539–551.
   PubMed Web of Science ®Google Scholar
• Schmich J, Kraus Y, De Vito D, et al. Induction of reverse development in two marine hydrozoans. Int J Dev Biol. 2007;51(1):45–56.
   PubMed Web of Science ®Google Scholar
• Sadasivam S, Duan S, DeCaprio JA. The MuvB complex sequentially recruits B-Myb and FoxM1 to promote mitotic gene expression. Genes Dev. 2012;26(5):474–489. doi: 10.1101/gad.181933.111
   PubMed Web of Science ®Google Scholar
• Schmit F, Cremer S, Gaubatz S. LIN54 is an essential core subunit of the DREAM/LINC complex that binds to the cdc2 promoter in a sequence-specific manner. FEBS J. 2009;276(19):5703–5716. doi: 10.1111/j.1742-4658.2009.07261.x
   PubMed Web of Science ®Google Scholar
• Müller GA, Engeland K. The central role of CDE/CHR promoter elements in the regulation of cell cycle-dependent gene transcription. FEBS J. 2010;277(4):877–893. doi: 10.1111/j.1742-4658.2009.07508.x
   PubMed Web of Science ®Google Scholar
• Müller GA, Quaas M, Schümann M, et al. The CHR promoter element controls cell cycle-dependent gene transcription and binds the DREAM and MMB complexes. Nucleic Acids Res. 2012;40(4):1561–1578.
   PubMed Web of Science ®Google Scholar
• Guiley KZ, Liban TJ, Felthousen JG, et al. Structural mechanisms of DREAM complex assembly and regulation. Genes Dev. 2015;29(9):961–974.
   PubMed Web of Science ®Google Scholar
• Fischer M, Müller GA. Cell cycle transcription control: DREAM/MuvB and RB-E2F complexes. Crit Rev Biochem Mol Biol. 2017;52:638–662. doi: 10.1080/1040923820171360836
   PubMed Web of Science ®Google Scholar
• Litovchick L, Florens LA, Swanson SK, et al. DYRK1A protein kinase promotes quiescence and senescence through DREAM complex assembly. Genes Dev. 2011;25(8):801–813.
   PubMed Web of Science ®Google Scholar
• Iness AN, Felthousen J, Ananthapadmanabhan V, et al. The cell cycle regulatory DREAM complex is disrupted by high expression of oncogenic B-Myb. Oncogene. 2018;38:1080–1092. 38:7 2018. doi: 10.1038/s41388-018-0490-y.
   PubMed Web of Science ®Google Scholar
• Quaas M, Müller GA, Engeland K. p53 can repress transcription of cell cycle genes through a p21(WAF1/CIP1)-dependent switch from MMB to DREAM protein complex binding at CHR promoter elements. Cell Cycle (Georgetown, Tex). 2012;11:4661–4672. doi: 10.4161/cc.22917
   PubMed Web of Science ®Google Scholar
• Horn HF, Vousden KH. Coping with stress: multiple ways to activate p53. Oncogene. 2007;26(9):1306–1316. doi: 10.1038/sj.onc.1210263
   PubMed Web of Science ®Google Scholar
• Fernandez-Rebollo E, Franzen J, Goetzke R, et al. Senescence-associated metabolomic phenotype in primary and iPSC-Derived mesenchymal stromal cells. Stem Cell Rep. 2020;14(2):201–209. doi: 10.1016/j.stemcr.2019.12.012
   PubMed Web of Science ®Google Scholar
• He S, Sharpless NE. Senescence in health and disease. Cell. 2017;169:1000–1000. doi: 10.1016/j.cell.2017.05.015
   PubMed Web of Science ®Google Scholar
• Borghesan M, Fafián-Labora J, Eleftheriadou O, et al. Small Extracellular Vesicles Are Key Regulators of Non-cell Autonomous Intercellular Communication in Senescence via the Interferon Protein IFITM3. Cell Rep. 2019;27(13):3956–3971.e6.
   PubMed Web of Science ®Google Scholar
• Song S, Tchkonia T, Jiang J, et al. Targeting senescent cells for a healthier ageing: challenges and opportunities. Adv Sci. 2020;7:2002611. doi: 10.1002/advs.202002611
   Web of Science ®Google Scholar
• Baker DJ, Wijshake T, Tchkonia T, et al. Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders. Nature. 2011;479(7372):232–236.
   PubMed Web of Science ®Google Scholar
• Jeon OH, Kim C, Laberge R-M, et al. Local clearance of senescent cells attenuates the development of post-traumatic osteoarthritis and creates a pro-regenerative environment. Nat Med. 2017;23(6):775–781.
   PubMed Web of Science ®Google Scholar
• Palmer AK, Xu M, Zhu Y, et al. Targeting senescent cells alleviates obesity-induced metabolic dysfunction. Ageing Cell. 2019;18:e12950. doi: 10.1111/acel.12950
   PubMed Web of Science ®Google Scholar
• Wang L, Wang B, Gasek NS, et al. Targeting p21Cip1 highly expressing cells in adipose tissue alleviates insulin resistance in obesity. Cell Metab. 2022;34(1):75–89.e8.
   PubMed Web of Science ®Google Scholar
• Sun Y, Li Q, Kirkland JL. Targeting senescent cells for a healthier longevity: the roadmap for an era of global ageing. Life Med. 2022;1:103–119. doi: 10.1093/lifemedi/lnac030
   PubMedGoogle Scholar
• Cai Y, Zhou H, Zhu Y, et al. Elimination of senescent cells by β-galactosidase-targeted prodrug attenuates inflammation and restores physical function in aged mice. Cell Res. 2020;30(7):574.
   PubMed Web of Science ®Google Scholar
• Xu M, Pirtskhalava T, Farr JN, et al. Senolytics improve physical function and increase lifespan in old age. Nature Med. 2018;24(8):1246–1256.
   PubMed Web of Science ®Google Scholar
• Krishnamurthy J, Torrice C, Ramsey MR, et al. Ink4a/Arf expression is a biomarker of ageing. J Clin Investig. 2004;114:1299–1307. doi: 10.1172/JCI22475
   PubMed Web of Science ®Google Scholar
• Gasek NS, Kuchel GA, Kirkland JL, et al. Strategies for targeting senescent cells in human disease. Nature Ageing. 2021;1:870–879. 1:10 2021. doi: 10.1038/s43587-021-00121-8.
   PubMedGoogle Scholar
• Xu M, Tchkonia T, Kirkland JL. Perspective: targeting the JAK/STAT pathway to fight age-related dysfunction. Pharmacol Res. 2016;111:152–154. doi: 10.1016/j.phrs.2016.05.015
   PubMed Web of Science ®Google Scholar
• Childs BG, Baker DJ, Kirkland JL, et al. Senescence and apoptosis: dueling or complementary cell fates? EMBO Reports. 2014;15:1139. doi: 10.15252/embr.201439245
   PubMed Web of Science ®Google Scholar
• Childs BG, Gluscevic M, Baker DJ, et al. Senescent cells: an emerging target for diseases of ageing. Nat Rev Drug Discov. 2017;16(10):718.
   PubMed Web of Science ®Google Scholar
• Zhang X, Zhang S, Liu X, et al. Oxidation resistance 1 is a novel senolytic target. Ageing Cell. 2018;17:12780. doi: 10.1111/acel.12780
   Web of Science ®Google Scholar
• Chang J, Wang Y, Shao L, et al. Clearance of senescent cells by ABT263 rejuvenates aged hematopoietic stem cells in mice. Nature Med. 2016;22(1):78.
   PubMed Web of Science ®Google Scholar
• Yosef R, Pilpel N, Tokarsky-Amiel R, et al. Directed elimination of senescent cells by inhibition of BCL-W and BCL-XL. Nat Commun. 2016 [[cited 2021 Nov 30]];7. /pmc/articles/PMC4823827/. doi: 10.1038/ncomms11190
   PubMed Web of Science ®Google Scholar
• Yang H, Chen C, Chen H, et al. Navitoclax (ABT263) reduces inflammation and promotes chondrogenic phenotype by clearing senescent osteoarthritic chondrocytes in osteoarthritis. Ageing. 2020;12:12750–12770. doi: 10.18632/aging.103177
   PubMedGoogle Scholar
• Ritschka B, Knauer-Meyer T, Gonçalves DS, et al. The senotherapeutic drug ABT-737 disrupts aberrant p21 expression to restore liver regeneration in adult mice. Genes Dev. 2020;34(7–8):489–494.
   PubMed Web of Science ®Google Scholar
• Yousefzadeh MJ, Zhu Y, McGowan SJ, et al. Fisetin is a senotherapeutic that extends health and lifespan. EBioMedicine. 2018;36:18. doi: 10.1016/j.ebiom.2018.09.015
   PubMed Web of Science ®Google Scholar
• Lilja S, Oldenburg J, Pointner A, et al. Epigallocatechin gallate effectively affects senescence and anti-SASP via SIRT3 in 3T3-L1 preadipocytes in comparison with other bioactive substances. Oxid Med Cell Longevity. 2020;2020:1–13. doi: 10.1155/2020/4793125
   Web of Science ®Google Scholar
• Kumar R, Sharma A, Kumari A, et al. Epigallocatechin gallate suppresses premature senescence of preadipocytes by inhibition of PI3K/Akt/mTOR pathway and induces senescent cell death by regulation of Bax/Bcl-2 pathway. Biogerontology. 2018;20:171–189. 20:2 2018. doi: 10.1007/s10522-018-9785-1.
   PubMed Web of Science ®Google Scholar
• Shin JH, Jeon HJ, Park J, et al. Epigallocatechin-3-gallate prevents oxidative stress-induced cellular senescence in human mesenchymal stem cells via Nrf2. Int J Mol Med. 2016;38(4):1075–1082. doi: 10.3892/ijmm.2016.2694
   PubMed Web of Science ®Google Scholar
• Liao VHC, Yu CW, Chu YJ, et al. Curcumin-mediated lifespan extension in caenorhabditis elegans. Mech Ageing Dev. 2011;132(10):480–487. doi: 10.1016/j.mad.2011.07.008
   PubMed Web of Science ®Google Scholar
• Lee KS, Lee BS, Semnani S, et al. Curcumin extends life span, improves health span, and modulates the expression of age-associated aging genes in drosophila melanogaster. Rejuvenation Res. 2010;13:561–570. https://home.liebertpub.com/rej
   PubMed Web of Science ®Google Scholar
• Pluta R, Ułamek-Kozioł M, Czuczwar SJ. Neuroprotective and neurological/cognitive enhancement effects of curcumin after brain ischemia injury with alzheimer’s disease phenotype. Int J Mol Sci. 2018;19(12):4002. doi: 10.3390/ijms19124002
   PubMed Web of Science ®Google Scholar
• Ray Hamidie RD, Yamada T, Ishizawa R, et al. Curcumin treatment enhances the effect of exercise on mitochondrial biogenesis in skeletal muscle by increasing cAMP levels. Metabolism. 2015;64(10):1334–1347.
   PubMed Web of Science ®Google Scholar
• Miao J, Liu J, Niu J, et al. Wnt/β-catenin/RAS signalling mediates age-related renal fibrosis and is associated with mitochondrial dysfunction. Ageing Cell. 2019;18:e13004. doi: 10.1111/acel.13004
   PubMed Web of Science ®Google Scholar
• Luo C, Zhou S, Zhou Z, et al. Wnt9a promotes renal fibrosis by accelerating cellular senescence in tubular epithelial cells. J Am Soc Nephrol. 2018;29(4):1238–1256.
   PubMed Web of Science ®Google Scholar
• Davis T, Brook AJC, Rokicki MJ, et al. Evaluating the role of p38 MAPK in the accelerated cell senescence of werner syndrome fibroblasts. Pharmaceuticals. 2016;9(2):23. doi: 10.3390/ph9020023
   Google Scholar
• Pakala R, Stabile E, Jang GJ, et al. Rapamycin attenuates atherosclerotic plaque progression in apolipoprotein E knockout mice: inhibitory effect on monocyte chemotaxis. J Cardiovasc Pharmacol. 2005;46(4):481–486. doi: 10.1097/01.fjc.0000177985.14305.15
   PubMed Web of Science ®Google Scholar
• Testai L, Piragine E, Piano I, et al. The citrus flavonoid naringenin protects the myocardium from ageing-dependent dysfunction: potential role of SIRT1. Oxid Med Cell Longevity. 2020;2020: doi: 10.1155/2020/4650207
   PubMed Web of Science ®Google Scholar
• Zhu Y, Tchkonia T, Pirtskhalava T, et al. The Achilles’ heel of senescent cells: from transcriptome to senolytic drugs. Ageing Cell. 2015;14:644–658. doi: 10.1111/acel.12344
   PubMed Web of Science ®Google Scholar
• Zhu Y, Tchkonia T, Fuhrmann-Stroissnigg H, et al. Identification of a novel senolytic agent, navitoclax, targeting the Bcl-2 family of anti-apoptotic factors. Ageing Cell. 2016;15:428–435. doi: 10.1111/acel.12445
   PubMed Web of Science ®Google Scholar
• Childs BG, Gluscevic M, Baker DJ, et al. Senescent cells: an emerging target for diseases of ageing. Nat Rev Drug Discov. 2017;16(10):718–735.
   PubMed Web of Science ®Google Scholar
• Baar MP, Brandt RMC, Putavet DA, et al. Targeted apoptosis of senescent cells restores tissue homeostasis in response to Chemotoxicity and aging. Cell. 2017;169(1):132–147.e16.
   PubMed Web of Science ®Google Scholar
• Zhu Y, Doornebal EJ, Pirtskhalava T, et al. New agents that target senescent cells: the flavone, fisetin, and the BCL-XL inhibitors, A1331852 and A1155463. Ageing (Albany NY). 2017;9:955. doi: 10.18632/aging.101202
   PubMedGoogle Scholar
• Debacq-Chainiaux F, Erusalimsky JD, Campisi J, et al. Protocols to detect senescence-associated beta-galactosidase (SA-betagal) activity, a biomarker of senescent cells in culture and in vivo. Nat Protoc. 2009;4:1798–1806. doi: 10.1038/nprot.2009.191
   PubMed Web of Science ®Google Scholar
• Childs BG, Durik M, Baker DJ, et al. Cellular senescence in ageing and age-related disease: from mechanisms to therapy. Nature Med. 2015;21:1424. doi: 10.1038/nm.4000
   PubMed Web of Science ®Google Scholar
• Hernandez-Segura A, Nehme J, Demaria M. Hallmarks of cellular senescence. Trends Cell Biol. 2018;28(6):436–453. doi: 10.1016/j.tcb.2018.02.001
   PubMed Web of Science ®Google Scholar
• Moysan E, Bastiat G, Benoit JP. Gemcitabine versus Modified Gemcitabine: a review of several promising chemical modifications. Mol Pharmaceut. 2013;10(2):430–444. doi: 10.1021/mp300370t
   PubMed Web of Science ®Google Scholar
• Mini E, Nobili S, Caciagli B, et al. Cellular pharmacology of gemcitabine. Annals Oncol Official J European Society Med Oncol. 2006 [cited 2022 Feb 16];17(Suppl 5). https://pubmed.ncbi.nlm.nih.gov/16807468/
   Google Scholar
• Plunkett W, Huang P, Gandhi V. Preclinical characteristics of gemcitabine. Anticancer Drugs. 1995;6(Supplement 6):7–13. doi: 10.1097/00001813-199512006-00002
   PubMedGoogle Scholar
• Sarkar AK, Fritz TA, Taylor WH, et al. Disaccharide uptake and priming in animal cells: inhibition of sialyl Lewis X by acetylated gal beta 1–>4GlcNAc beta-O-naphthalenemethanol. Proc Natl Acad Sci USA. 1995;92:3323–3327. doi: 10.1073/pnas.92.8.3323
   PubMed Web of Science ®Google Scholar
• Tilstra JS, Robinson AR, Wang J, et al. NF-κB inhibition delays DNA damage-induced senescence and ageing in mice. J Clin Investig. 2012;122:2601–2612. doi: 10.1172/JCI45785
   PubMed Web of Science ®Google Scholar
• Kang HT, Park JT, Choi K, et al. Chemical screening identifies ATM as a target for alleviating senescence. Nat Chem Biol. 2017;13:616–623. doi: 10.1038/nchembio.2342
   PubMed Web of Science ®Google Scholar
• Lee SJ, Jung YS, Yoon MH, et al. Interruption of progerin-lamin A/C binding ameliorates hutchinson-gilford progeria syndrome phenotype. J Clin Investig. 2016;126:3879–3893. doi: 10.1172/JCI84164
   PubMed Web of Science ®Google Scholar
• Yang HH, Hwangbo K, Zheng MS, et al. Inhibitory effects of juglanin on cellular senescence in human dermal fibroblasts. J Nat Med. 2014;68:473–480. doi: 10.1007/s11418-014-0817-0
   PubMed Web of Science ®Google Scholar
• Yang HH, Hwangbo K, Zheng MS, et al. Quercetin-3-O-β-D-glucuronide isolated from Polygonum aviculare inhibits cellular senescence in human primary cells. Arch Pharm Res. 2014;37:1219–1233. doi: 10.1007/s12272-014-0344-2
   PubMed Web of Science ®Google Scholar
• Yang HH, Hwangbo K, Zheng MS, et al. Inhibitory effects of (-)-loliolide on cellular senescence in human dermal fibroblasts. Arch Pharm Res. 2015;38:876–884. doi: 10.1007/s12272-014-0435-0
   PubMed Web of Science ®Google Scholar
• Yang HH, Zhang H, Son JK, et al. Inhibitory effects of quercetagetin 3,4’-dimethyl ether purified from Inula japonica on cellular senescence in human umbilical vein endothelial cells. Arch Pharm Res. 2015;38:1857–1864. doi: 10.1007/s12272-015-0577-8
   PubMed Web of Science ®Google Scholar
• Bae YU, Choi JH, Nagy A, et al. Antisenescence effect of mouse embryonic stem cell conditioned medium through a PDGF/FGF pathway. FASEB J. 2016;30:1276–1286. doi: 10.1096/fj.15-278846
   PubMed Web of Science ®Google Scholar
• Bae YU, Son Y, Kim CH, et al. Embryonic stem cell-Derived mmu-miR-291a-3p inhibits cellular senescence in human dermal fibroblasts through the TGF-β receptor 2 pathway. J Gerontol Ser A. 2019;74:1359–1367. doi: 10.1093/gerona/gly208
   PubMed Web of Science ®Google Scholar
• Kim EC, Kim JR. Senotherapeutics: emerging strategy for healthy ageing and age-related disease. BMB Rep. 2019;52:47. doi: 10.5483/BMBRep.2019.52.1.293
   PubMed Web of Science ®Google Scholar
• Liu P, Zhao H, Luo Y. Anti-ageing implications of astragalus membranaceus (Huangqi): a well-known Chinese tonic. Aging Dis. 2017;8:868–886. doi: 10.14336/AD.2017.0816
   PubMed Web of Science ®Google Scholar
• Wei M, Brandhorst S, Shelehchi M, et al. Fasting-mimicking diet and markers/risk factors for ageing, diabetes, cancer, and cardiovascular disease. Sci Transl Med. 2017 [[cited 2022 Nov 29]];9. Available from: https://pubmed.ncbi.nlm.nih.gov/28202779/
   PubMed Web of Science ®Google Scholar
• Lamming DW, Ye L, Sabatini DM, et al. Rapalogs and mTOR inhibitors as anti-ageing therapeutics. J Clin Investig. 2013;123:980–989. doi: 10.1172/JCI64099
   PubMed Web of Science ®Google Scholar
• Si H, Liu D. Dietary antiageing phytochemicals and mechanisms associated with prolonged survival. J Nutr Biochem. 2014;25:581–591. doi: 10.1016/j.jnutbio.2014.02.001
   PubMed Web of Science ®Google Scholar
• Soto-Gamez A, Demaria M. Therapeutic interventions for ageing: the case of cellular senescence. Drug Discovery Today. 2017;22:786–795. doi: 10.1016/j.drudis.2017.01.004
   PubMed Web of Science ®Google Scholar
• Nakamura S, Yoshimori T. Autophagy and longevity. Mol Cells. 2018;41(1):65–72. doi: 10.14348/molcells.2018.2333
   PubMed Web of Science ®Google Scholar
• Schafer MJ, Miller JD, LeBrasseur NK. Cellular senescence: Implications for metabolic disease. Mol Cell Endocrinol. 2017;455:93–102. doi: 10.1016/j.mce.2016.08.047
   PubMed Web of Science ®Google Scholar
• Wiley CD, Brumwell AN, Davis SS, et al. Secretion of leukotrienes by senescent lung fibroblasts promotes pulmonary fibrosis. JCI Insight. 2019;4(24):4.
   Web of Science ®Google Scholar
• Di Leonardo A, Linke SP, Clarkin K, et al. DNA damage triggers a prolonged p53-dependent G1 arrest and long-term induction of Cip1 in normal human fibroblasts. Genes Dev. 1994;8(21):2540–2551.
   PubMed Web of Science ®Google Scholar
• Calcinotto A, Kohli J, Zagato E, et al. Cellular senescence: Ageing, cancer, and injury. Physiol Rev. 2019;99:1047–1078. doi: 10.1152/physrev.00020.2018
   PubMed Web of Science ®Google Scholar
• Sharpless NE, DePinho RA. Cancer: crime and punishment. Nature. 2005;436(7051):636–637. doi: 10.1038/436636a
   PubMed Web of Science ®Google Scholar
• Baker DJ, Sedivy JM. Probing the depths of cellular senescence. J Cell Bio. 2013;202(1):11–13. doi: 10.1083/jcb.201305155
   PubMed Web of Science ®Google Scholar
• Cheung TH, Rando TA. Molecular regulation of stem cell quiescence. Nat Rev Mol Cell Biol. 2013;14(6):329–340. doi: 10.1038/nrm3591
   PubMed Web of Science ®Google Scholar
• Anders L, Ke N, Hydbring P, et al. A systematic screen for CDK4/6 substrates links FOXM1 phosphorylation to senescence suppression in cancer cells. Cancer Cell. 2011;20(5):620–634.
   PubMed Web of Science ®Google Scholar
• Nogueira V, Park Y, Chen CC, et al. Akt determines replicative senescence and oxidative or oncogenic premature senescence and sensitizes cells to oxidative apoptosis. Cancer Cell. 2008;14(6):458–470.
   PubMed Web of Science ®Google Scholar
• Miyauchi H, Minamino T, Tateno K, et al. Akt negatively regulates the in vitro lifespan of human endothelial cells via a p53/p21-dependent pathway. EMBO J. 2004;23(1):212–220.
   PubMed Web of Science ®Google Scholar
• Imai Y, Takahashi A, Hanyu A, et al. Crosstalk between the Rb pathway and AKT signalling forms a quiescence-senescence switch. Cell Rep. 2014;7:194–207. doi: 10.1016/j.celrep.2014.03.006
   PubMed Web of Science ®Google Scholar
• Demidenko ZN, Korotchkina LG, Gudkov AV, et al. Paradoxical suppression of cellular senescence by p53. Proc Natl Acad Sci USA. 2010;107:9660–9664. doi: 10.1073/pnas.1002298107
   PubMed Web of Science ®Google Scholar
• Korotchkina LG, Leontieva OV, Bukreeva EI, et al. The choice between p53-induced senescence and quiescence is determined in part by the mTOR pathway. Ageing. 2010;2:344–352. doi: 10.18632/aging.100160
   PubMedGoogle Scholar
• McCay CM, Crowell MF, Maynard LA. The effect of retarded growth upon the length of life span and upon the ultimate body SizeOne Figure. J Nutr. 1935;10(1):63–79. doi: 10.1093/jn/10.1.63
   Google Scholar